Study wrapper · #245
Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.
Editor's note
An anti-doping method paper, not a clinical study. The authors validated an immunoaffinity-purification plus nano-LC high-resolution mass-spectrometry assay able to isolate and detect twelve prohibited peptides simultaneously from plasma, serum, or urine — including native GHRH(1-29) and CJC-1295, alongside insulins, Synacthen, LH-RH, and IGF-1 analogues — at low picogram-per-millilitre levels. CJC-1295 features purely as one analytical target in a multiplex screen; the emphasis is on a fast, commercially reproducible sample-prep workflow (about 25 samples per day) that other labs could adopt. There is no physiological, efficacy, or safety content. For readers, this is regulatory infrastructure: it confirms CJC-1295 is detectable at physiologically relevant urinary concentrations. It has no bearing on whether the peptide does anything beneficial; that question rests on a separate, small body of Phase II human PK/PD data.
Plain-language abstract
This paper describes a laboratory method for detecting banned peptide hormones in the very small amounts (picograms per millilitre) at which they appear in blood or urine. Because these concentrations are so low, samples must be purified and concentrated before analysis. The researchers combined an antibody-based purification step with a highly sensitive detection technique (nano-scale liquid chromatography linked to high-resolution mass spectrometry). Their method could purify and identify twelve prohibited peptides at once, including several insulins, synthetic ACTH (Synacthen), a hormone called LH-RH, growth-hormone-releasing hormone GHRH(1-29), the GHRH analogue CJC-1295, and IGF-1 and a related analogue. For each peptide type they used a matching antibody and an internal reference standard to keep results reliable. The detection limits were in the low picogram-per-millilitre range in urine. The sample preparation was fast (about 25 samples a day) and used only commercially available materials, so other laboratories — in forensics or pharmacology — could adopt it. The study is about detection only and reports nothing about the effects or safety of CJC-1295 or the other substances.